Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients

BACKGROUND: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. OBJECTIVE: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipie...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandari Naji, H., Ghorbanihaghjo, A., Argani, H., Raeisi, S., Safa, J., Alirezaei, A. H., Rashtchizadeh, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549008/
https://www.ncbi.nlm.nih.gov/pubmed/28828171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549008/
https://www.ncbi.nlm.nih.gov/pubmed/28828171

Ejemplares similares